These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9729522)

  • 1. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.
    Fahey JL
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):597-603. PubMed ID: 9729522
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.
    Aziz N; Nishanian P; Fahey JL
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):755-61. PubMed ID: 9801330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
    Sulkowski MS; Chaisson RE; Karp CL; Moore RD; Margolick JB; Quinn TC
    J Infect Dis; 1998 Dec; 178(6):1642-8. PubMed ID: 9815216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
    J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.
    Roberts L; Passmore JA; Williamson C; Little F; Bebell LM; Mlisana K; Burgers WA; van Loggerenberg F; Walzl G; Djoba Siawaya JF; Karim QA; Karim SS
    AIDS; 2010 Mar; 24(6):819-31. PubMed ID: 20224308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct relationship between virus load and systemic immune activation in HIV-2 infection.
    Leligdowicz A; Feldmann J; Jaye A; Cotten M; Dong T; McMichael A; Whittle H; Rowland-Jones S
    J Infect Dis; 2010 Jan; 201(1):114-22. PubMed ID: 19938978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection.
    Salazar-Gonzalez JF; Martinez-Maza O; Aziz N; Kolberg JA; Yeghiazarian T; Shen LP; Fahey JL
    Clin Immunol Immunopathol; 1997 Jul; 84(1):36-45. PubMed ID: 9191882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute HIV-1 seroconversion with an unusual plasma biomarker profile.
    Aziz N; Detels R; Martinez-Maza O; Oishi J; Jamieson BD; Witt MD; Butch AW
    Clin Vaccine Immunol; 2013 Nov; 20(11):1774-7. PubMed ID: 24006141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new plasma biomarkers in HIV-1-infected African-American women.
    Poli G
    AIDS; 2011 Sep; 25(15):1921-3. PubMed ID: 21914979
    [No Abstract]   [Full Text] [Related]  

  • 11. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.
    Fahey JL; Aziz N; Spritzler J; Plaeger S; Nishanian P; Lathey JL; Seigel J; Landay AL; Kilarui R; Schmitz JL; White C; Wara DW; Akridge R; Cutili J; Douglas SD; Reuben J; Shearer WT; Nokta M; Polland R; Schooley R; Asthana D; Mizrachi Y; Waxdal M
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):540-8. PubMed ID: 10882648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals.
    Konadu KA; Chu J; Huang MB; Amancha PK; Armstrong W; Powell MD; Villinger F; Bond VC
    J Infect Dis; 2015 Jun; 211(11):1712-6. PubMed ID: 25512626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.
    Aziz N; Nishanian P; Taylor JM; Mitsuyasu RT; Jacobson JM; Dezube BJ; Lederman MM; Detels R; Fahey JL
    J Infect Dis; 1999 Apr; 179(4):843-8. PubMed ID: 10068579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers predicting progression of human immunodeficiency virus-related disease.
    Tsoukas CM; Bernard NF
    Clin Microbiol Rev; 1994 Jan; 7(1):14-28. PubMed ID: 8118788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
    Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
    PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-inducible protein 10 (IP-10) is associated with viremia of early HIV-1 infection in Korean patients.
    Lee S; Chung YS; Yoon CH; Shin Y; Kim S; Choi BS; Kim SS
    J Med Virol; 2015 May; 87(5):782-9. PubMed ID: 25678246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
    Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
    J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment.
    Singh D; Ghate M; Godbole S; Kulkarni S; Thakar M
    Front Immunol; 2018; 9():1152. PubMed ID: 29881390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire.
    Nkengasong JN; Kestens L; Ghys PD; Koblavi-Dème S; Bilé C; Kalou M; Ya LK; Traoré-Ettiègne V; Maurice C; Laga M; Wiktor SZ; Greenberg AE
    J Infect Dis; 2001 May; 183(9):1405-8. PubMed ID: 11294674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.